-
1.发明授权Electrode apparatus and method for the delivery of drugs and genes into tissue 失效用于将药物和基因递送到组织中的电极装置和方法公开(公告)号：US07395110B2
公开(公告)日：2008-07-01
申请号：US10783164
申请日：2004-02-20
IPC分类号： A61N1/30
CPC分类号： A61N1/0424 , A61N1/042 , A61N1/0436 , A61N1/044 , A61N1/30 , A61N1/325
摘要： An electrode assembly for an apparatus for trans-surface molecular includes a non-conductive carrier having a proximal surface, a distal surface, and a plurality of through holes from the proximal surface to the distal surface, a plurality of first electrodes disposed on the proximal surface, a first conductor disposed on at least a first portion of the distal surface and extending through at least a first portion of the plurality of through holes and connected to the first electrodes on the proximal surface, a plurality of second electrodes disposed on the proximal surface, and a second conductor disposed on at least a second portion of the distal surface and extending through at least a second portion of the plurality of through holes and connected to the second electrodes on the proximal surface, wherein the first electrodes and the second electrodes are configured and disposed in closely spaced relation on the proximal surface for engaging the tissue surface and applying an electric field.
摘要翻译： 用于反式表面分子的装置的电极组件包括具有近端表面，远端表面和从近端表面到远端表面的多个通孔的非导电载体，多个第一电极，其设置在近端 表面，设置在所述远端表面的至少第一部分上并延伸穿过所述多个通孔的至少第一部分并且连接到所述近端表面上的所述第一电极的第一导体，设置在所述近端的多个第二电极 表面和第二导体，其设置在远端表面的至少第二部分上并且延伸穿过多个通孔的至少第二部分并且连接到近端表面上的第二电极，其中第一电极和第二电极 在近侧表面上以紧密间隔的关系配置和设置，用于接合组织表面并施加电极 c字段。
-
2.发明申请Minimizing Metal Toxicity During Electroporation Enhanced Delivery of Polynucleotides 审中-公开电穿孔期间金属毒性最小化增强多核苷酸的递送公开(公告)号：US20080215032A1
公开(公告)日：2008-09-04
申请号：US10516757
申请日：2003-03-25
申请人： Dietmar P. Rabussay
发明人： Dietmar P. Rabussay
IPC分类号： A61N1/30 , A61M31/00 , A61N1/32 , A61N1/05 , A61K31/7088
CPC分类号： C12N15/87 , A61K48/0083
摘要： Methods are provided for introducing a polynucleotide into healthy tissue and generating a pulsed electric field in the tissue via invasive electrodes, resulting in enhanced delivery of the polynucleotide into cells of the tissue, while minimizing local side effects to the electroporated tissue and systemic side effects to the electroporated organism due to metal contaminants released from said electrodes. In one embodiment, the invention methods Use electrodes of gold, gold alloys, or other metal that minimize the introduction of toxic amounts of the metal into electroporated tissue. In other embodiments, the invention methods are utilized for the gene therapy by administering DNA to cells of suitable target tissue, and for the induction of an immune response by administration of a DNA vaccine.
摘要翻译： 提供了用于将多核苷酸引入健康组织中并通过侵入电极在组织中产生脉冲电场的方法，导致多核苷酸进入组织细胞的增强递送，同时最小化对电穿孔组织的局部副作用和全身副作用 由于从所述电极释放的金属污染物导致的电穿孔生物体。 在一个实施方案中，本发明方法使用金，金合金或其它金属的电极，其将毒性量的金属引入电穿孔组织中最小化。 在其它实施方案中，本发明方法用于通过向合适的靶组织的细胞施用DNA以及通过施用DNA疫苗来诱导免疫应答来进行基因治疗。
-
公开(公告)号：US4355022A
公开(公告)日：1982-10-19
申请号：US279536
申请日：1981-07-01
申请人： Dietmar P. Rabussay
发明人： Dietmar P. Rabussay
摘要： A dental and gum treatment agent and method uses the isolated and purified enzyme species lysozyme as a primary active substance to attack and destroy in situ the cariogenic bacteria in the oral cavity forming the plaque-calculus substrate and causing gum disorders. The agent operates to penetrate the bacterial cell wall and thereby destroy existing bacteria by disintegration so that residues are washed away. Auxiliary isolated enzymes of the groups of lipases, carbohydrases, phospholipases and proteases are used as additives to decrease treatment time as an aid to penetration of cell walls of gram (-) type bacteria. EDTA (ethylene diamino tetraacetic acid) is also used as an additive to remove ionic bonds that could clamp and stabilize bacterial walls to some extent after the lysozyme action. Thus, an aqueous solution of about 0.1 mg/ml of isolated lysozyme with or without controlled addition of known additives is effective in an oral cavity application for a few minutes to treat dental caries by removal of plaque and calculus, and to control gum infections.
摘要翻译： 牙科和牙龈处理剂和方法使用分离和纯化的酶物质溶菌酶作为主要活性物质来攻击和破坏口腔中形成斑块微积体底物的致龋细菌并引起牙龈疾病。 该试剂操作以穿透细菌细胞壁，从而通过分解破坏现有的细菌，使残留物被冲走。 使用脂肪酶，糖酶，磷脂酶和蛋白酶组的辅助分离酶作为添加剂以减少治疗时间，以辅助克（ - ）型细菌的细胞壁的渗透。 还可以使用EDTA（乙二胺四乙酸）作为添加剂去除在溶菌酶作用后可以将细菌壁夹紧并稳定到一定程度的离子键。 因此，通过或不加控制添加已知添加剂的约0.1mg / ml分离的溶菌酶的水溶液在口腔应用中几分钟可有效地通过去除斑块和牙垢来治疗龋齿，并且控制牙龈感染。
-
4.发明授权Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation 有权通过非侵入性体内电穿孔增强裸DNA的表达公开(公告)号：US07922709B2
公开(公告)日：2011-04-12
申请号：US11291459
申请日：2005-11-30
申请人： Lei Zhang , Dietmar P. Rabussay
发明人： Lei Zhang , Dietmar P. Rabussay
IPC分类号： A61N1/30
摘要： In vivo methods are provided for using an electric field to delivery therapeutic or immunizing treatment to a subject by applying non-invasive, user-friendly electrodes to the surface of the skin. Thus, therapeutic or immunizing agents can be delivered into cells of skin for local and systemic treatments or for immunization with optimal gene expression and minimal tissue damage. In particular, therapeutic agents include naked or formulated nucleic acid, polypeptides and chemotherapeutic agents.
摘要翻译： 提供体内方法，通过将非侵入性的，用户友好的电极施加到皮肤表面，使用电场来传递对受试者的治疗或免疫治疗。 因此，治疗或免疫剂可以递送到皮肤细胞中用于局部和全身治疗或用最佳基因表达和最小组织损伤进行免疫。 特别地，治疗剂包括裸体或配制的核酸，多肽和化学治疗剂。
-
公开(公告)号：US06697669B2
公开(公告)日：2004-02-24
申请号：US09352809
申请日：1999-07-13
申请人： Nagendu B. Dev , Gunter A. Hofmann , Edward Nolan , Dietmar P. Rabussay , Arnt Tonnessen , Georg Widera , Lei Zhang
发明人： Nagendu B. Dev , Gunter A. Hofmann , Edward Nolan , Dietmar P. Rabussay , Arnt Tonnessen , Georg Widera , Lei Zhang
IPC分类号： A61N130
CPC分类号： A61N1/327 , A61N1/0424 , A61N1/0452 , A61N1/306 , A61N1/325
摘要： The present invention describes an in vivo method, using pulsed electric field to deliver therapeutic agents into cells of the skin and muscle for local and systemic treatments. In particular, therapeutic agents include naked or formulated nucleic acid, polypeptides and chemotherapeutic agents.
-
6.发明授权Intradermal delivery of active agents by needle-free injection and electroporation 有权通过无针注射和电穿孔活性剂的皮内递送公开(公告)号：US07171264B1
公开(公告)日：2007-01-30
申请号：US10339708
申请日：2003-01-08
IPC分类号： A61N1/30
CPC分类号： A61N1/0424 , A61N1/0428 , A61N1/325
摘要： Methods are proved for introducing a biologically active agent into cells of a subject by introducing the agent in a form suitable for electrotransport into a region of tissue of the subject using one or more needle-free injectors, and applying a pulsed electric field to the region of tissue, thereby causing electroporation of the region of tissue. The combination of needle-free injection and electroporation is sufficient to introduce the agent into cells in skin, muscle or mucosa. For example, the region of tissue can be contacted with two oppositely charged injectors, one acting as the donor electrode and one acting as the counter electrode, or a single injector and one or more electrodes can be used. In addition, needle-free injection may be used in combination with suitable non-invasive electrode configurations. The active agents delivered into cells using the invention method can be small molecules, polynucleotides, polypeptides, and the like.
摘要翻译： 证明通过使用一种或多种无针注射器将适合于电转移到受试者组织区域的形式引入生物活性剂来引入生物活性剂的方法，以及向该区域施加脉冲电场 的组织，从而引起组织区域的电穿孔。 无针注射和电穿孔的组合足以将药剂引入皮肤，肌肉或粘膜中的细胞中。 例如，组织区域可以与两个相反电荷的注射器接触，一个充当施主电极，另一个充当对电极，或者可以使用单个注射器和一个或多个电极。 此外，无针注射可以与合适的非侵入性电极结构组合使用。 使用本发明方法递送到细胞中的活性剂可以是小分子，多核苷酸，多肽等。
-
公开(公告)号：US07570992B2
公开(公告)日：2009-08-04
申请号：US10756946
申请日：2004-01-13
申请人： Edward Nolan , Dietmar P. Rabussay , Georg Widera , Lei Zhang
发明人： Edward Nolan , Dietmar P. Rabussay , Georg Widera , Lei Zhang
摘要： In vivo methods are provided for using an electric field to delivery therapeutic treatment to a subject while reducing inducement of histopathological change in the target muscle tissue, such as is associated with induction or amplification of an immune response caused by the pulsed electric field. Therapeutic agents can be delivered nto cells of muscle for local and systemic treatments with optimal gene expression and minimal tissue damage. In particular, therapeutic agents include naked or formulated nucleic acid, polypeptides and chemotherapeutic agents.
摘要翻译： 提供体内方法，用于使电场向受试者递送治疗性治疗，同时减少诱导靶肌肉组织中的组织病理学变化，例如与由脉冲电场引起的免疫应答的诱导或扩增相关。 治疗剂可以递送到肌肉细胞，用于局部和全身治疗，具有最佳的基因表达和最小的组织损伤。 特别地，治疗剂包括裸体或配制的核酸，多肽和化学治疗剂。
-
8.发明授权Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation 有权通过非侵入性体内电穿孔增强裸DNA的表达公开(公告)号：US06972013B1
公开(公告)日：2005-12-06
申请号：US10233007
申请日：2002-08-30
申请人： Lei Zhang , Dietmar P. Rabussay
发明人： Lei Zhang , Dietmar P. Rabussay
摘要： In vivo methods are provided for using an electric field to delivery therapeutic or immunizing treatment to a subject by applying non-invasive, user-friendly electrodes to the surface of the skin. Thus, therapeutic or immunizing agents can be delivered into cells of skin for local and systemic treatments or for immunization with optimal gene expression and minimal tissue damage. In particular, therapeutic agents include naked or formulated nucleic acid, polypeptides and chemotherapeutic agents.
摘要翻译： 提供体内方法，通过将非侵入性的，用户友好的电极施加到皮肤表面，使用电场来传递对受试者的治疗或免疫治疗。 因此，治疗或免疫剂可以递送到皮肤细胞中用于局部和全身治疗或用最佳基因表达和最小组织损伤进行免疫。 特别地，治疗剂包括裸体或配制的核酸，多肽和化学治疗剂。
-
9.发明授权Electrode apparatus and method for the delivery of drugs and genes into tissue 失效用于将药物和基因递送到组织中的电极装置和方法公开(公告)号：US06748265B2
公开(公告)日：2004-06-08
申请号：US09847468
申请日：2001-05-02
IPC分类号： A61N130
CPC分类号： A61N1/0424 , A61N1/042 , A61N1/0436 , A61N1/044 , A61N1/30 , A61N1/325
摘要： An electrode assembly for an apparatus for trans-surface molecular includes a non-conductive carrier having a proximal surface, a distal surface, and a plurality of through holes from the proximal surface to the distal surface, a plurality of first electrodes disposed on the proximal surface, a first conductor disposed on at least a first portion of the distal surface and extending through at least a first portion of the plurality of through holes and connected to the first electrodes on the proximal surface, a plurality of second electrodes disposed on the proximal surface, and a second conductor disposed on at least a second portion of the distal surface and extending through at least a second portion of the plurality of through holes and connected to the second electrodes on the proximal surface, wherein the first electrodes and the second electrodes are configured and disposed in closely spaced relation on the proximal surface for engaging the tissue surface and applying an electric field.
摘要翻译： 用于反式表面分子的装置的电极组件包括具有近端表面，远端表面和从近端表面到远端表面的多个通孔的非导电载体，多个第一电极，其设置在近端 表面，设置在所述远端表面的至少第一部分上并延伸穿过所述多个通孔的至少第一部分并且连接到所述近端表面上的所述第一电极的第一导体，设置在所述近端的多个第二电极 表面和第二导体，其设置在远端表面的至少第二部分上并且延伸穿过多个通孔的至少第二部分并且连接到近端表面上的第二电极，其中第一电极和第二电极 在近侧表面上以紧密间隔的关系配置和设置，用于接合组织表面并施加电极 c字段。
-
10.发明授权公开(公告)号：US06678556B1
公开(公告)日：2004-01-13
申请号：US10165657
申请日：2002-06-07
申请人： Edward Nolan , Dietmar P. Rabussay , Georg Widera , Lei Zhang
发明人： Edward Nolan , Dietmar P. Rabussay , Georg Widera , Lei Zhang
IPC分类号： A61N130
摘要： In vivo methods are provided for using an electric field to delivery therapeutic treatment to a subject while reducing inducement of histopathological change in the target muscle tissue, such as is associated with induction or amplification of an immune response caused by the pulsed electric field. Therapeutic agents can be delivered nto cells of muscle for local and systemic treatments with optimal gene expression and minimal tissue damage. In particular, therapeutic agents include naked or formulated nucleic acid, polypeptides and chemotherapeutic agents.
摘要翻译： 提供体内方法，用于使电场向受试者递送治疗性治疗，同时减少诱导靶肌肉组织中的组织病理学变化，例如与由脉冲电场引起的免疫应答的诱导或扩增相关。 治疗剂可以递送到肌肉细胞，用于局部和全身治疗，具有最佳的基因表达和最小的组织损伤。 特别地，治疗剂包括裸体或配制的核酸，多肽和化学治疗剂。
-
-
-
-
-
-
-
-
-
搜索结果
12 条记录 (耗时 0.018 秒)
